(NP (NP Activation/NN) (PP of/IN (NP NF-kappa/NN B/NN)) (PP by/IN (NP interleukin/NN 2/CD)) (PP in/IN (NP human/JJ blood/NN monocytes/NNS)) ./.)
(S (NP-SBJ We/PRP) (VP report/VBP (ADVP here/RB) (SBAR that/IN (S (NP-SBJ-28 (NP interleukin/NN 2/CD) (PRN -LRB-/-LRB- (NP IL-2/NN) -RRB-/-RRB-)) (VP acts/VBZ (PP on/IN (NP human/JJ blood/NN monocytes/NNS)) (PP by/IN (S (NP-SBJ *-28/-NONE-) (VP enhancing/VBG (NP (NP binding/NN activity/NN) (PP of/IN (NP the/DT transcription/NN factor/NN NF-kappa/NN B/NN)) (PP to/TO (NP (NP its/PRP$ consensus/NN sequence/NN) (PP in/IN (NP (NP (NP the/DT 5'/JJ regulatory/JJ enhancer/NN region/NN) (PP of/IN (NP the/DT IL-2/NN receptor/NN alpha/NN chain/NN))) (PRN -LRB-/-LRB- (NP p55/NN) -RRB-/-RRB-))))))))))))) ./.)
(S (ADVP Similarly/RB) ,/, (NP-SBJ IL-2/NN) (VP activates/VBZ (NP NF-kappa/NN B/NN) (PP-COOD (PP in/IN (NP the/DT human/JJ monocytic/JJ cell/NN line/NN U/NN 937/CD)) ,/, but/CC (PP not/RB in/IN (NP resting/VBG human/JJ T-cells/NNS)))) ./.)
(S (NP-SBJ This/DT effect/NN) (VP-COOD (VP is/VBZ (ADJP-PRD detectable/JJ) (PP-TMP within/IN (NP 15/CD min/NN))) and/CC (VP peaks/VBZ (PP-TMP (NP 1/CD h/NN) after/IN (NP (NP exposure/NN) (PP to/TO (NP IL-2/NN)))))) ./.)
(S (NP-SBJ-29 Enhanced/VBN NF-kappa/NN B/NN binding/NN activity/NN) (VP is/VBZ (VP followed/VBN (NP *-29/-NONE-) (PP by/IN (NP-LGS (NP functional/JJ activation/NN) (WHPP-105 in/IN (SBAR-COOD (SBAR (WHNP that/IN) (S (NP-SBJ-30 (NP inducibility/NN) (PP of/IN (NP the/DT IL-2/NN receptor/NN alpha/NN chain/NN))) (VP is/VBZ (VP mediated/VBN (NP *-30/-NONE-) (PP by/IN (NP-LGS enhanced/VBN NF-kappa/NN B/NN binding/NN)) (PP *T*-105/-NONE-))))) and/CC (SBAR (WHNP that/IN) (S (NP-SBJ-31 (NP a/DT heterologous/JJ promoter/NN) (VP containing/VBG (NP (NP (NP the/DT NF-kappa/NN B/NN consensus/NN sequence/NN) (PRN -LRB-/-LRB- (NP-COOD (NP -291/CD) to/TO (NP -245/CD)) -RRB-/-RRB-)) (PP of/IN (NP the/DT IL-2/NN receptor/NN alpha/NN chain/NN gene/NN))))) (VP is/VBZ (VP activated/VBN (NP *-31/-NONE-) (PP *T*-105/-NONE-))))))))))) ./.)
(S-COOD (S (PP In/IN (NP addition/NN)) ,/, (NP-SBJ-32 IL-2/NN) (VP is/VBZ (ADJP-PRD capable/JJ (PP of/IN (S (NP-SBJ *-32/-NONE-) (VP increasing/VBG (NP (NP transcript/NN levels/NNS) (PP of/IN (NP (NP the/DT p50/NN gene/NN) (VP coding/VBG (PP for/IN (NP (NP the/DT p50/NN subunit/NN) (PP of/IN (NP the/DT NF-kappa/NN B/NN transcription/NN factor/NN)))))))))))))) ,/, whereas/IN (S (NP-SBJ (NP mRNA/NN levels/NNS) (PP of/IN (NP the/DT p65/NN NF-kappa/NN B/NN gene/NN))) (VP remained/VBD (ADJP-PRD unchanged/JJ))) ./.)
